Back
Innate Pharma SA Stock Price Chart

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
IPHA
Innate Pharma SA
Last Price:
$2.03
Seasonality Move:
-3.76%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPHA is experiencing slight buying pressure.
Innate Pharma SA Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.97 | Buy |
20-day SMA: | 2.02 | Sell |
50-day SMA: | 1.95 | Buy |
200-day SMA: | 2.04 | Sell |
8-day EMA: | 1.96 | Buy |
20-day EMA: | 2 | Sell |
50-day EMA: | 1.98 | Sell |
200-day EMA: | 2.07 | Sell |
Innate Pharma SA Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 48.08 | Sell |
Chaikin Money Flow: | 3524 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.96 - 2.18) | Sell |
Bollinger Bands (100): | (1.63 - 2.13) | Buy |
Innate Pharma SA Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 1.97 while IPHA 8-day simple moving average is 1.97, which is a Buy signal.
-
The stock price of IPHA is 1.97 while Innate Pharma SA 20-day SMA is 2.02, which makes it a Sell.
-
Innate Pharma SA 50-day simple moving average is 1.95 while IPHA share price is 1.97, making it a Buy technically.
-
IPHA stock price is 1.97 and Innate Pharma SA 200-day simple moving average is 2.04, creating a Sell signal.
IPHA Technical Analysis vs Fundamental Analysis
Buy
54
Innate Pharma SA (IPHA)
is a Buy
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a BuyThe current Innate Pharma SA [IPHA] share price is $1.97. The Score for IPHA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Innate Pharma SA Stock Info
Market Cap:
159.5M
Price in USD:
1.97
Share Volume:
14.1K
Innate Pharma SA 52-Week Range
52-Week High:
3.51
52-Week Low:
1.29
Buy
54
Innate Pharma SA (IPHA)
is a Buy
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?The Innate Pharma SA stock price is 1.97 USD today.
-
Will IPHA stock go up or go down?Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators
-
Is Innate Pharma SA overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is not overvalued.
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 1.97 while IPHA 8-day exponential moving average is 1.96, which is a Buy signal.
-
The stock price of IPHA is 1.97 while Innate Pharma SA 20-day EMA is 2.00, which makes it a Sell.
-
Innate Pharma SA 50-day exponential moving average is 1.98 while IPHA share price is 1.97, making it a Sell technically.
-
IPHA stock price is 1.97 and Innate Pharma SA 200-day simple moving average is 2.07, creating a Sell signal.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
-
IPHA Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Innate Pharma SA is a Sell
-
Innate Pharma SA Relative Strength Index (RSI) is 48.08, which suggest Innate Pharma SA is oversold
-
The Bollinger Bands (25) for Innate Pharma SA is (1.96 - 2.18), which suggest Innate Pharma SA is a Buy
-
The Bollinger Bands (100) for Innate Pharma SA is (1.63 - 2.13), which suggest Innate Pharma SA is a Buy
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.